166 related articles for article (PubMed ID: 11163546)
1. Relationship of extrapyramidal symptoms to age at onset and drug treatment in middle-aged and elderly schizophrenic patients.
Srinivasan TN; Thara R; Padmavathi R; McCreadie RG
Schizophr Res; 2001 Jan; 47(1):69-75. PubMed ID: 11163546
[TBL] [Abstract][Full Text] [Related]
2. Clinical relationship of extrapyramidal symptoms and tardive dyskinesia.
Andrew HG
Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S76-80. PubMed ID: 7874668
[TBL] [Abstract][Full Text] [Related]
3. Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients.
Spivak B; Mester R; Abesgaus J; Wittenberg N; Adlersberg S; Gonen N; Weizman A
J Clin Psychiatry; 1997 Jul; 58(7):318-22. PubMed ID: 9269253
[TBL] [Abstract][Full Text] [Related]
4. Treatment predictors of extrapyramidal side effects in patients with tardive dyskinesia: results from Veterans Affairs Cooperative Study 394.
Lohr JB; Caligiuri MP; Edson R; Lavori P; Adler LA; Rotrosen J; Hitzemann R
J Clin Psychopharmacol; 2002 Apr; 22(2):196-200. PubMed ID: 11910266
[TBL] [Abstract][Full Text] [Related]
5. Drug-induced parkinsonism in relation to choline-containing compounds measured by 1H-MR spectroscopy in putamen of chronically medicated patients with schizophrenia.
Yamasue H; Fukui T; Fukuda R; Kasai K; Iwanami A; Kato N; Kato T
Int J Neuropsychopharmacol; 2003 Dec; 6(4):353-60. PubMed ID: 14604450
[TBL] [Abstract][Full Text] [Related]
6. Drug-induced parkinsonism: relationship to age at onset of schizophrenia.
Sandyk R; Kay SR
Funct Neurol; 1991; 6(2):151-7. PubMed ID: 1680777
[TBL] [Abstract][Full Text] [Related]
7. Acute extrapyramidal syndromes in neuroleptic-treated elders: a pilot study.
Ganzini L; Heintz R; Hoffman WF; Keepers GA; Casey DE
J Geriatr Psychiatry Neurol; 1991; 4(4):222-5. PubMed ID: 1686396
[TBL] [Abstract][Full Text] [Related]
8. The psychological consequences of tardive dyskinesia. The effect of drug-induced parkinsonism and the topography of the dyskinetic movements.
Brown KW; White T
Br J Psychiatry; 1991 Sep; 159():399-403. PubMed ID: 1683594
[TBL] [Abstract][Full Text] [Related]
9. Extrapyramidal symptoms in unmedicated schizophrenia.
McCreadie RG; Srinivasan TN; Padmavati R; Thara R
J Psychiatr Res; 2005 May; 39(3):261-6. PubMed ID: 15725424
[TBL] [Abstract][Full Text] [Related]
10. Extrapyramidal syndromes and new antipsychotic drugs: findings in patients and non-human primate models.
Casey DE
Br J Psychiatry Suppl; 1996 May; (29):32-9. PubMed ID: 8733821
[No Abstract] [Full Text] [Related]
11. Prevalence of and Risk Factors for Extrapyramidal Side Effects of Antipsychotics: Results From the National FACE-SZ Cohort.
Misdrahi D; Tessier A; Daubigney A; Meissner WG; Schurhoff F; Boyer L; Godin O; Bulzacka E; Aouizerate B; Andrianarisoa M; Berna F; Capdevielle D; Chereau-Boudet I; D'Amato T; Dubertret C; Dubreucq J; Faget-Agius C; Lançon C; Mallet J; Passerieux C; Rey R; Schandrin A; Urbach M; Vidailhet P; Llorca PM; Fond G;
J Clin Psychiatry; 2019 Jan; 80(1):. PubMed ID: 30695288
[TBL] [Abstract][Full Text] [Related]
12. Neuroleptic drug-induced extrapyramidal syndromes and tardive dyskinesia.
Casey DE
Schizophr Res; 1991; 4(2):109-20. PubMed ID: 1674881
[TBL] [Abstract][Full Text] [Related]
13. The inter-relationships of tardive dyskinesia, parkinsonism, akathisia and tardive dystonia: the Curaçao Extrapyramidal Syndromes Study II.
van Harten PN; Hoek HW; Matroos GE; Koeter M; Kahn RS
Schizophr Res; 1997 Aug; 26(2-3):235-42. PubMed ID: 9323356
[TBL] [Abstract][Full Text] [Related]
14. Abnormal movements in never-medicated Indian patients with schizophrenia.
McCreadie RG; Thara R; Kamath S; Padmavathy R; Latha S; Mathrubootham N; Menon MS
Br J Psychiatry; 1996 Feb; 168(2):221-6. PubMed ID: 8837914
[TBL] [Abstract][Full Text] [Related]
15. Neurodevelopmental origins of tardivelike dyskinesia in schizophrenia patients and their siblings.
Ismail B; Cantor-Graae E; McNeil TF
Schizophr Bull; 2001; 27(4):629-41. PubMed ID: 11824489
[TBL] [Abstract][Full Text] [Related]
16. The influence of topography on the cognitive and psychopathological effects of tardive dyskinesia.
Brown KW; White T
Am J Psychiatry; 1992 Oct; 149(10):1385-9. PubMed ID: 1356314
[TBL] [Abstract][Full Text] [Related]
17. Metric characteristics of the drug-induced extrapyramidal symptoms scale (DIEPSS): a practical combined rating scale for drug-induced movement disorders.
Kim JH; Jung HY; Kang UG; Jeong SH; Ahn YM; Byun HJ; Ha KS; Kim YS
Mov Disord; 2002 Nov; 17(6):1354-9. PubMed ID: 12465082
[TBL] [Abstract][Full Text] [Related]
18. Movement disorder in never and minimally treated Nigerian schizophrenic patients.
McCreadie RG; Ohaeri JU
Br J Psychiatry; 1994 Feb; 164(2):184-9. PubMed ID: 7909712
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and clinical correlates of extrapyramidal signs and spontaneous dyskinesia in never-medicated schizophrenic patients.
Chatterjee A; Chakos M; Koreen A; Geisler S; Sheitman B; Woerner M; Kane JM; Alvir J; Lieberman JA
Am J Psychiatry; 1995 Dec; 152(12):1724-9. PubMed ID: 8526237
[TBL] [Abstract][Full Text] [Related]
20. No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients.
Silver H; Geraisy N; Schwartz M
J Clin Psychiatry; 1995 Apr; 56(4):167-70. PubMed ID: 7713856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
